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The heart is a hidden organ; although ancient physicians could feel its pulse, they could not approach its structure and function. Today, different imaging modalities such as echocardiography, 1,2 computed tomography (CT 3 ), magnetic resonance imaging (MRI), and nuclear scans are available and have enabled modern management of heart disease. The most recent progress is reviewed by Victoria Delgado from the Leiden University Medical Center in the Netherlands, and colleagues in the article 'The year in cardiology: imaging'. 4 The authors note that while conventional imaging to assess cardiac structure and function is still the first approach, multimodality imaging for coronary disease 5, 6 and for endocarditis 7 as well as artificial intelligence applied to imaging is about to change clinical practice. Also, advanced echocardiography with strain imaging techniques, 8 tissue characterization with cardiovascular magnetic resonance to assess outcomes 9 and arrhythmic risk, 10 and assessment of biological processes with nuclear imaging techniques have helped to diagnose endocarditis 7 and understand that early intervention may be needed in order to prevent or halt the progression of the disease. By applying machine learning techniques to all these imaging modalities, algorithms can be generated that can identify certain patterns of disease or risk and develop decisions in a more personalized way ( Figure 1 ). 11 Chronic inflammation is a major driver of endothelial dysfunction and plaque formation. [12] [13] [14] Such inflammation is a novel therapeutic target in primary and secondary prevention. However, detecting residual inflammatory risk in individual patients is hampered by the lack of reliable imaging modalities to guide targeted use of antiinflammatory strategies in clinical practice. In their review entitled 'Imaging residual inflammatory cardiovascular risk', Charalambos Antoniades and colleagues from the University of Oxford in the UK point out that current diagnostic tests for the detection of coronary inflammation are either non-specific, such as C-reactive protein, or expensive and not readily available (as is the case with hybrid positron emission tomography imaging). 15 Recent advancements in coronary computed tomography angiography (CCTA) allow for non-invasive detection of high-risk plaque features, e.g. positive remodelling, spotty calcification, low attenuation plaque, and napkin ring sign, among others. 17 However, such structural features provide only indirect information about coronary inflammation. The perivascular fat attenuation index, a novel method for assessing coronary inflammation by analysing routine coronary CT, captures changes in the perivascular adipose tissue composition driven by inflammatory signals coming from the inflamed coronary artery, by analysing the 3-D gradients of perivascular attenuation, followed by adjustments for technical, anatomical, and biological factors ( Figure 2 ). By detecting vascular inflammation, the perivascular fat attenuation index enhances cardiovascular risk discrimination, which could aid more cost-effective deployment of novel therapeutic agents. In short-a further step towards personalized prevention.
Positron emission tomography or PET myocardial perfusion imaging allows for non-invasive assessment of myocardial blood flow reserve. 18 In their article 'Myocardial blood flow reserve assessed by positron emission tomography myocardial perfusion imaging identifies patients with a survival benefit from early revascularization' Krishna Patel and colleagues from the Saint Luke's Mid America Heart Institute in Kansas City, USA examined whether myocardial blood flow reserve using 82 Rubidium PET at rest and during stress identifies patients with a survival benefit after revascularization. 19 After a median follow-up of 3.2 years, 897 of the 12 594 patients or 7.1% underwent early revascularization and 13.5% died. Ischaemia was present in 32.3%, with 11.2% presenting with ischaemia of at least 10% of the myocardium. Mean myocardial blood flow reserve was 2.0 ± 1.3, while in 38.5% it was <1.8. After multivariable adjustment, every 0.1 unit decrease in myocardial blood flow reserve was associated with a 9% hazard ratio of 1.09 each of all-cause death. Further, there was a significant interaction between myocardial blood flow reserve and early revascularization such that patients with a myocardial blood flow reserve of <1.8 had a survival benefit with early revascularization. Thus, myocardial blood flow reserve on PET perfusion imaging is associated with all-cause mortality and can identify those benefiting from early revascularization compared with medical therapy. These clinically important finding are put into context in an Editorial by Oliver Gaemperli from the University of Zurich in Switzerland. 20 Besides classical risk factors and inflammation, physical and psychological stress can affect cardiac function via neurogenic mechanisms. 21 Noise is a novel stress factor that has been recognized to affect cardiovascular outcomes. 22 The mechanism involved in noise-induced stress in humans is further pursued in the manuscript entitled 'A neurobiological mechanism linking transportation noise to cardiovascular disease in humans' by Ahmed Tawakol and colleagues from the Massachusetts General Hospital Department of Radiology in Boston, USA. 23 The amygdala, a limbic centre involved in stress perception, participates in the response to noise. Over a median 4.06 years, 40 of the 498 individuals, or 8%, experienced major cardiovascular events or MACE. Higher noise exposure (per 5 dBA increase) predicted MACE, with a hazard ratio of 1.34 even after multivariable adjustments. Higher noise exposure was associated with increased amygdalar metabolic activity. Mediation analysis suggested that higher noise exposure is associated with MACE via a serial mechanism involving heightened amygdalar metabolic activity and arterial inflammation that accounts for 12-26% of this relationship. Thus, noise exposure is associated with MACE via a mechanism that is triggered by increased stress-induced amygdalar activity and arterial inflammation. This potential neurobiological mechanism linking noise to cardiovascular events merits further evaluation in a prospective population, as Thomas Münzel from the Johannes Gutenberg Universität in Mainz, Germany outlines in his balanced Editorial. 24 Vascular calcification is routinely encountered in percutaneous coronary intervention (PCI), and severe coronary calcification is a known predictor of in-stent restenosis and stent thrombosis. 25, 26 In their manuscript 'Vascular responses to coronary calcification following implantation of newer-generation drug-eluting stents in humans: impact on healing' Aloke Virmani Finn and colleagues from CVPATH in Gaithersburg in the USA note that the histopathological mechanisms behind such events remain to be characterized. 27 They histologically analysed 1211 newer-generation drug-eluting stents, implanted for more than 30 days. The extent of calcification of the stented lesions was evaluated radiographically and divided into severely and non-severely calcified lesions. The percentage of uncovered struts per section and the presence of severe medial tears were greater in severely calcified than in non-severely calcified lesions. In addition, severely calcified lesions had a higher prevalence of three or more consecutive struts lying directly in contact with the surface calcified area. Multivariate analysis demonstrated that sections with duration of implantation less than 6 months, three or more consecutive struts in contact with the surface calcified area, strut malapposition, and lack of medial tears were independent . . . . . . . . . . . predictors of uncovered struts. Prevalence of neoatherosclerosis was significantly lower in severely calcified than in non-severely calcified lesions. Thus, severe calcification, especially surface calcified area, is an independent predictor of uncovered struts and delayed healing after newer-generation drug-eluting stent implantation. How to best to deal with calcifications in patients undergoing PCI is further discussed in an educational Editorial by Yoshinobu Onuma from the Thorax Centre in Rotterdam, the Netherlands. 28
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DetecƟon of inflammaƟon (FAI-CTA, NaF-PET) Implemented Treatment 6.5% of populaƟon will develop obstrucƟve plaques It is estimated that 6.5% of the general population will develop obstructive coronary artery disease during their lifetime. At the early stages of disease, before the clinical manifestations of atherosclerosis, cardiovascular risk stratification is based on the assessment of the clinical profile and the use of risk scoring systems (which usually have modest predictive accuracy). In asymptomatic subjects, risk prediction can be further enhanced by coronary calcium scoring. Non-invasive diagnostic assessment of symptomatic subjects relies on functional stress imaging or anatomical assessment by coronary computed tomography angiography. However, 50% of acute coronary syndromes occur in patients without any obstructive plaques, 16 for whom usual imaging tests are of limited diagnostic value. Novel, accurate, and cost-effective ways for cardiovascular risk discrimination (e.g. assessment of coronary inflammatory burden) would allow the deployment of more effective prevention treatment strategies and save lives, but appropriate screening tools for the detection of coronary inflammation have been lacking (from Antoniades C, Antonopoulos AS, Deanfield J. Imaging residual inflammatory cardiovascular risk. See pages 748-758).
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